Nant Capital, LLC (CIK 1675758) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-04-02). Recent activity: Buy IBRX (4.6M shares), Buy IBRX (114,329 shares), Sell IBRX (58,170 shares), Buy IBRX (274,122 shares), Sell IBRX (118,560 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-02 | ImmunityBio, Inc. (IBRX) | Insider | Buy | 4.6M | $25.0M |
| 2026-02-24 | ImmunityBio, Inc. (IBRX) | Insider | Buy | 114,329 | $0 |
| 2026-02-24 | ImmunityBio, Inc. (IBRX) | Insider | Sell | 58,170 | $506,079 |
| 2026-02-12 | ImmunityBio, Inc. (IBRX) | Insider | Buy | 274,122 | $0 |
| 2026-02-12 | ImmunityBio, Inc. (IBRX) | Insider | Sell | 118,560 | $821,621 |
| 2025-02-25 | ImmunityBio, Inc. (IBRX) | Insider | Buy | 114,329 | $0 |
| 2025-02-25 | ImmunityBio, Inc. (IBRX) | Insider | Sell | 42,071 | $143,883 |
Source: SEC Form 4 filings · as of 2026-04-02